BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6419593)

  • 1. Auranofin versus placebo in the treatment of rheumatoid arthritis.
    Wenger ME; Alexander S; Bland JH; Blechman WJ
    Am J Med; 1983 Dec; 75(6A):123-7. PubMed ID: 6419593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis.
    Katz WA; Alexander S; Bland JH; Blechman W; Bluhm GB; Bonebrake RA; Falbo A; Greenwald RA; Hartman S; Hobbs T; Indenbaum S; Lergier JE; Lanier BG; Lightfoot RW; Phelps P; Sheon RP; Torretti D; Wenger ME; Wilske K
    J Rheumatol Suppl; 1982; 8():173-8. PubMed ID: 6813481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An European open multicentre trial with auranofin in rheumatoid arthritis.
    Raeman F; Hanssens F; Delattre M
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():33-8. PubMed ID: 6432411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
    Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Subsets of responses.
    Ward JR; Williams HJ; Boyce E; Egger MJ; Reading JC; Samuelson CO
    Am J Med; 1983 Dec; 75(6A):133-7. PubMed ID: 6419595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of oral and parenteral gold therapy and placebo in the treatment of rheumatoid arthritis.
    Williams HJ; Ward JR
    Scand J Rheumatol Suppl; 1983; 51():92-9. PubMed ID: 6426054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Cooperative systematic studies of rheumatic diseases.
    Williams HJ; Ward JR; Egger MJ; Reading JC; Samuelson CO; Altz-Smith M; Willkens RW; Solsky MA; Hayes SP; Furst D
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():39-50. PubMed ID: 6432412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multicenter double-blind comparison of auranofin and Tauredon].
    Kaik B; Bröll H
    Wien Klin Wochenschr Suppl; 1984; 156():33-40. PubMed ID: 6442055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of auranofin and aurothioglucose in the treatment of rheumatoid arthritis: a single blind study.
    van Riel PL; van de Putte LB; Gribnau FW; Macrae KD
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():51-6. PubMed ID: 6432414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Auranofin in the treatment of chronic polyarthritis. Results of an open multicenter study].
    Siegmeth W
    Wien Klin Wochenschr Suppl; 1984; 156():27-33. PubMed ID: 6442053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auranofin: a unique oral chrysotherapeutic agent.
    Blodgett RC; Heuer MA; Pietrusko RG
    Semin Arthritis Rheum; 1984 Feb; 13(3):255-73. PubMed ID: 6427927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early experiences with auranofin in juvenile rheumatoid arthritis.
    Brewer EJ; Giannini EH; Person DA
    Am J Med; 1983 Dec; 75(6A):152-6. PubMed ID: 6419599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auranofin or D-penicillamine in the treatment of rheumatoid arthritis.
    Hochberg MC
    Ann Intern Med; 1986 Oct; 105(4):528-35. PubMed ID: 3092712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial.
    Ward JR; Williams HJ; Egger MJ; Reading JC; Boyce E; Altz-Smith M; Samuelson CO; Willkens RF; Solsky MA; Hayes SP
    Arthritis Rheum; 1983 Nov; 26(11):1303-15. PubMed ID: 6416259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 12-month comparative trial of auranofin and D-penicillamine in rheumatoid arthritis.
    Felix-Davies DD; Stewart AM; Wilkinson BR; Bateman JR; Delamere JP
    Am J Med; 1983 Dec; 75(6A):138-41. PubMed ID: 6419596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auranofin and D-penicillamine: a one year comparative study of safety and efficacy in patients with rheumatoid arthritis followed by a two year open assessment of auranofin.
    Franchimont P; Hauwaert C; Vanschoubroek K
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():75-82. PubMed ID: 6432417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
    Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H
    J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Auranofin: experience to date.
    Blodgett RC
    Am J Med; 1983 Dec; 75(6A):86-9. PubMed ID: 6419601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worldwide clinical experience with auranofin.
    Morris RW; Cole DS; Horton J; Heuer MA; Pietrusko RG
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():105-11. PubMed ID: 6432408
    [No Abstract]   [Full Text] [Related]  

  • 20. Auranofin in the treatment of rheumatoid arthritis. A two-year study.
    Baldassare AR; Weiss TD; Arthur RE; Osborn TG; Moore TL; Zuckner J
    Mo Med; 1985 Nov; 82(11):711-5. PubMed ID: 3934512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.